RaySearch Laboratories AB (publ) (RAY-B.ST)
SEK 205.0
(1.49%)
SEK 205.0
(1.49%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | 185.67 Million SEK | -53.01% |
| 2022 | 395.11 Million SEK | -13.89% |
| 2021 | 458.86 Million SEK | 2144.94% |
| 2020 | -22.43 Million SEK | -139.46% |
| 2019 | 56.86 Million SEK | 194.66% |
| 2018 | 19.3 Million SEK | 194.74% |
| 2017 | -20.37 Million SEK | 22.22% |
| 2016 | -26.19 Million SEK | -21.6% |
| 2015 | -21.54 Million SEK | -43.71% |
| 2014 | -14.98 Million SEK | 59.01% |
| 2013 | -36.56 Million SEK | 40.91% |
| 2012 | -61.87 Million SEK | -115.56% |
| 2011 | -28.7 Million SEK | 61.74% |
| 2010 | -75.01 Million SEK | 6.25% |
| 2009 | -80.01 Million SEK | -13.26% |
| 2008 | -70.64 Million SEK | 10.73% |
| 2007 | -79.13 Million SEK | -18.41% |
| 2006 | -66.83 Million SEK | -24.66% |
| 2005 | -53.61 Million SEK | -536.18% |
| 2004 | -8.42 Million SEK | -35.57% |
| 2003 | -6.21 Million SEK | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | 64.64 Million SEK | -25.08% |
| 2024 Q1 | 86.28 Million SEK | -53.53% |
| 2023 Q2 | 277.98 Million SEK | -6.17% |
| 2023 Q4 | 185.67 Million SEK | -7.0% |
| 2023 Q3 | 199.64 Million SEK | -28.18% |
| 2023 FY | 185.67 Million SEK | -53.01% |
| 2023 Q1 | 296.26 Million SEK | -25.02% |
| 2022 FY | 395.11 Million SEK | -13.89% |
| 2022 Q3 | 414.27 Million SEK | 7.26% |
| 2022 Q4 | 395.11 Million SEK | -4.62% |
| 2022 Q1 | 397.04 Million SEK | -13.47% |
| 2022 Q2 | 386.23 Million SEK | -2.72% |
| 2021 Q4 | 458.86 Million SEK | 966.06% |
| 2021 Q2 | -50.38 Million SEK | 23.6% |
| 2021 Q3 | -52.98 Million SEK | -5.16% |
| 2021 Q1 | -65.95 Million SEK | -193.92% |
| 2021 FY | 458.86 Million SEK | 2144.94% |
| 2020 FY | -22.43 Million SEK | -139.46% |
| 2020 Q2 | 206 Thousand SEK | -99.72% |
| 2020 Q3 | -31.47 Million SEK | -15379.61% |
| 2020 Q4 | -22.43 Million SEK | 28.71% |
| 2020 Q1 | 73.23 Million SEK | 28.77% |
| 2019 FY | 56.86 Million SEK | 194.66% |
| 2019 Q1 | 151.69 Million SEK | 685.96% |
| 2019 Q2 | 55 Million SEK | -63.74% |
| 2019 Q3 | 77.99 Million SEK | 41.78% |
| 2019 Q4 | 56.86 Million SEK | -27.08% |
| 2018 Q2 | 13.59 Million SEK | 139.18% |
| 2018 Q4 | 19.3 Million SEK | -72.07% |
| 2018 FY | 19.3 Million SEK | 194.74% |
| 2018 Q1 | -34.7 Million SEK | -70.34% |
| 2018 Q3 | 69.1 Million SEK | 408.31% |
| 2017 Q3 | -58.99 Million SEK | 1.14% |
| 2017 Q2 | -59.67 Million SEK | -81.55% |
| 2017 Q4 | -20.37 Million SEK | 65.47% |
| 2017 Q1 | -32.86 Million SEK | -25.49% |
| 2017 FY | -20.37 Million SEK | 22.22% |
| 2016 FY | -26.19 Million SEK | -21.6% |
| 2016 Q2 | 2.6 Million SEK | 114.88% |
| 2016 Q1 | -17.49 Million SEK | 18.79% |
| 2016 Q4 | -26.19 Million SEK | -256.9% |
| 2016 Q3 | 16.69 Million SEK | 541.34% |
| 2015 FY | -21.54 Million SEK | -43.71% |
| 2015 Q4 | -21.54 Million SEK | -547.28% |
| 2015 Q2 | -820 Thousand SEK | 95.02% |
| 2015 Q1 | -16.46 Million SEK | -9.81% |
| 2015 Q3 | 4.81 Million SEK | 687.32% |
| 2014 FY | -14.98 Million SEK | 59.01% |
| 2014 Q3 | 146 Thousand SEK | 103.69% |
| 2014 Q1 | -34.74 Million SEK | 4.96% |
| 2014 Q2 | -3.96 Million SEK | 88.6% |
| 2014 Q4 | -14.98 Million SEK | -10366.44% |
| 2013 Q2 | -42.61 Million SEK | 31.59% |
| 2013 FY | -36.56 Million SEK | 40.91% |
| 2013 Q4 | -36.56 Million SEK | -8.0% |
| 2013 Q3 | -33.85 Million SEK | 20.56% |
| 2013 Q1 | -62.29 Million SEK | -0.67% |
| 2012 FY | -61.87 Million SEK | -115.56% |
| 2012 Q1 | -39.57 Million SEK | -37.86% |
| 2012 Q3 | -43.23 Million SEK | 13.13% |
| 2012 Q4 | -61.87 Million SEK | -43.1% |
| 2012 Q2 | -49.77 Million SEK | -25.77% |
| 2011 Q1 | -71.66 Million SEK | 4.47% |
| 2011 FY | -28.7 Million SEK | 61.74% |
| 2011 Q2 | -47.9 Million SEK | 33.15% |
| 2011 Q3 | -44.01 Million SEK | 8.12% |
| 2011 Q4 | -28.7 Million SEK | 34.79% |
| 2010 Q1 | -78.17 Million SEK | 2.3% |
| 2010 FY | -75.01 Million SEK | 6.25% |
| 2010 Q4 | -75.01 Million SEK | 2.86% |
| 2010 Q3 | -77.22 Million SEK | 5.93% |
| 2010 Q2 | -82.09 Million SEK | -5.01% |
| 2009 Q4 | -80.01 Million SEK | 0.0% |
| 2009 FY | -80.01 Million SEK | -13.26% |
| 2008 FY | -70.64 Million SEK | 10.73% |
| 2007 FY | -79.13 Million SEK | -18.41% |
| 2006 FY | -66.83 Million SEK | -24.66% |
| 2005 FY | -53.61 Million SEK | -536.18% |
| 2004 FY | -8.42 Million SEK | -35.57% |
| 2003 FY | -6.21 Million SEK | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Aino Health AB (publ) | -1.27 Million SEK | 14708.733% |
| Bonzun AB (publ) | 351 Thousand SEK | -52799.43% |
| Kontigo Care AB (publ) | -3.9 Million SEK | 4858.508% |
| Medhelp Care Aktiebolag (publ) | -8.26 Million SEK | 2346.546% |
| Surgical Science Sweden AB (publ) | -581.1 Million SEK | 131.953% |